News & Analysis on Clinical Trial Services & Contract Research And Development
A newly discovered process that explains how the body's nervous system relays information, may depend on how "wet" the "kiss" is when one neuron fires a packet of neurotransmitter across a synapse to a receptive nerve cell.
Agilent introduces its next generation of assay kits for its 2100 Bioanalyser Lab-on-a-Chip platform that aims to replace labour-intensive SDS-PAGE and capillary gel electrophoresis (CGE) methods providing faster microfluidic analyses.
Velocity11 make available a benchtop microplate handling system that claims to provide the features and flexibility of much larger and more expensive automation platforms.
AstraZeneca has pulled the plug on a long-running service contract with PDI, adding another blow to the company who last week reported a dive from profit to loss in 2005, with a net loss of nearly $20m (€16m), versus net income of $21m in 2004,...
New research has suggested only seven per cent of drug applications for treating people with rare diseases were approved in Europe between 2000 and 2004, despite the fact that there are currently more than 5,000 conditions needing medication.
Perceptive Informatics, a subsidiary of Parexel, has released the latest version of its web interface for data capture, patient randomisation and the management of study drug inventory for clinical trials.
A new study has revealed the existence of new drug targets for tuberculosis (TB) treatments, which could essentially dictate the design of TB drugs of the future. The bacterium that causes TB currently infects one person in three worldwide.